Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Cardiovascular Imaging
When measuring LV volumes on Echo using ultrasound enhancing agents, are you using different volume cut offs?
If so, is there a good reference paper?
Related Questions
When would you consider using cardiac MRI over nuclear imaging for functional assessment of ischemic heart disease, since it is class IIa indication in the US but otherwise class I in Europe?
What is a reasonable imaging modality for older patients with pAfib already on systemic anticoagulation outpatient but presenting with suspected cardioembolic stroke and TTE without evidence of LV thrombus?
What is your preferred imaging modality for the evaluation of coronary microvascular dysfunction/INOCA and when would you favor it over coronary angiogram with provocative testing?
Should there be age cut-off considerations when ordering TTEs with bubble routinely as part of stroke work-up?
What stress testing modality do you choose to evaluate patients who are unable to exercise and have anomalous coronary arteries?
What are some TTE findings that suggest worsening function of a bioprosthetic AVR that would require further surveillance or diagnostic imaging?
What is the clinical significance of intracardiac vacuum(s) noted during diastole, especially in terms of the diagnosis and management of diastolic dysfunction?
What is a reasonable stepwise approach to diagnostic imaging when there is ongoing concern for cardiac amyloidosis?
When do you favor using cardiac CT compared to TEE for outpatient surveillance in the immediate post-Watchman period?
What is your preferred imaging modality--cMR vs. TTE--to evaluate for myocardial strain if concerned for chemotherapy-induced cardiomyopathies?